SCHEMBL30837899

SCHEMBL30837899

CCOc1ccc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)cc1OCC

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.83
PDE7B Q9NP56 5/20 0.83
PDE8A O60658 3/20 0.83
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
S1PR1 P21453 1/20 0.34
CASR P41180 1/20 0.34
OPRL1 P41146 2/20 0.34
OPRM1 P35372 1/20 0.34
GAA P10253 1/20 0.33
USP2 O75604 1/20 0.33
GLA P06280 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100754 1.00 PDE7A (0.83) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100171 0.96 PDE7A (0.90) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100843 0.96 PDE7A (0.78) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL101004 0.94 PDE7A (0.75) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837934 0.94 PDE7A (0.75) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100773 0.93 PDE7A (0.77) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100063 0.92 PDE7A (0.82) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100985 0.92 PDE7A (0.77) PDE7APDE7BPDE8AMAPTMAPK1
SCHEMBL100220 0.91 PDE7A (0.70) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100704 0.91 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed